Anzeige
Mehr »
Login
Montag, 25.05.2020 Börsentäglich über 12.000 News von 629 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von PMLiVE

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrAZ secures capacity for one billion coronavirus vaccine doses
FrEMA starts review of MorphoSys' tafasitamab for lymphoma
FrGilead, Galapagos dip on mixed ulcerative colitis data
DoRoche makes protein degradation play with $135m Vividion deal
DoOctapharma cleared to start phase 3 trial of Octagam in COVID-19
DoUK government expands coronavirus testing criteria
DoRecruiting for a COVID-19 clinical trial?
DoMedical affairs - a strategic function for scientific engagement
MiFDA gives Roche's Tecentriq green light for first-line NSCLC
MiTrailing Clovis, AstraZeneca gets FDA approval for Lynparza in prostate cancer
MiBiopharma body welcomes EU-UK free trade agreement docs
MiThe far-reaching impact of the COVID-19 pandemic on clinical trials
DiModerna's coronavirus vaccine hits first objectives
DiFocusing on patient centricity to build trust in pharma
DiNovartis claims EU approval for SMA gene therapy Zolgensma
DiFDA clears phase 2 COVID-19 trial of ViralClear's merimepodib
18.05.New truths and realities in these strange times
18.05.After the watershed: the dos and don'ts of digital KPIs in a post-pandemic world
18.05.UK pledges £131m for a "rapid deployment facility" to make coronavirus vaccines
18.05.AZ, Daiichi Sankyo's Enhertu fast-tracked in US for NSCLC
18.05.ViiV takes on Gilead's PReP dominance with HIV injectable data
18.05.Taking the 'free' out of 'freelance' and bringing it in-house
15.05.BMS sets out its first-line NSCLC stall at ASCO
15.05.Sanofi in the firing line over 'US-first' COVID-19 vaccine plan
15.05.Merck's Keytruda hits the mark in triple negative breast cancer